Flume PA - Search Results

1

A pilot study of the efficacy of constant-infusion ceftazidime in the treatment of endobronchial infections in adults with cystic fibrosis.

Bosso JA, Bonapace CR, Flume PA, White RL. Bosso JA, et al. Among authors: flume pa. Pharmacotherapy. 1999 May;19(5):620-6. doi: 10.1592/phco.19.8.620.31525. Pharmacotherapy. 1999. PMID: 10331825 Clinical Trial.

2

Current and novel therapies for cystic fibrosis.

Flume PA. Flume PA. J S C Med Assoc. 1996 Sep;92(9):381-8. J S C Med Assoc. 1996. PMID: 8854578 Review. No abstract available.

3

In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Manduru M, Mihm LB, White RL, Friedrich LV, Flume PA, Bosso JA. Manduru M, et al. Among authors: flume pa. Antimicrob Agents Chemother. 1997 Sep;41(9):2053-6. doi: 10.1128/AAC.41.9.2053. Antimicrob Agents Chemother. 1997. PMID: 9303416 Free PMC article.

4

Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method.

Manduru M, Mihm LB, White RL, Friedrich LV, Flume PA, Bosso JA. Manduru M, et al. Among authors: flume pa. Antimicrob Agents Chemother. 1997 Nov;41(11):2527-32. doi: 10.1128/AAC.41.11.2527. Antimicrob Agents Chemother. 1997. PMID: 9371361 Free PMC article.

5

Complications of cystic fibrosis in adults.

Nichols PL, Flume P. Nichols PL, et al. J S C Med Assoc. 2000 Mar;96(3):112-7. J S C Med Assoc. 2000. PMID: 10812878 No abstract available.

6

Psychological functioning of adults with cystic fibrosis.

Anderson DL, Flume PA, Hardy KK. Anderson DL, et al. Among authors: flume pa. Chest. 2001 Apr;119(4):1079-84. doi: 10.1378/chest.119.4.1079. Chest. 2001. PMID: 11296173

7

The rationale for aerosolized antibiotics.

Flume P, Klepser ME. Flume P, et al. Pharmacotherapy. 2002 Mar;22(3 Pt 2):71S-79S. doi: 10.1592/phco.22.6.71s.33909. Pharmacotherapy. 2002. PMID: 11898884 Review.

8

Probability of IV antibiotic retreatment within thirty days is associated with duration and location of IV antibiotic treatment for pulmonary exacerbation in cystic fibrosis.

VanDevanter DR, Flume PA, Morris N, Konstan MW. VanDevanter DR, et al. Among authors: flume pa. J Cyst Fibros. 2016 Nov;15(6):783-790. doi: 10.1016/j.jcf.2016.04.005. Epub 2016 Apr 29. J Cyst Fibros. 2016. PMID: 27139161 Free PMC article.

9

In Vitro Activity of Ceftolozane/Tazobactam vs Nonfermenting, Gram-Negative Cystic Fibrosis Isolates.

Forrester JB, Steed LL, Santevecchi BA, Flume P, Palmer-Long GE, Bosso JA. Forrester JB, et al. Open Forum Infect Dis. 2018 Jul 2;5(7):ofy158. doi: 10.1093/ofid/ofy158. eCollection 2018 Jul. Open Forum Infect Dis. 2018. PMID: 30046642 Free PMC article.

10

A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.

Goss CH, Heltshe SL, West NE, Skalland M, Sanders DB, Jain R, Barto TL, Fogarty B, Marshall BC, VanDevanter DR, Flume PA; STOP2 Investigators. Goss CH, et al. Among authors: flume pa. Am J Respir Crit Care Med. 2021 Dec 1;204(11):1295-1305. doi: 10.1164/rccm.202102-0461OC. Am J Respir Crit Care Med. 2021. PMID: 34469706 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

221 results

Search Page

Filters